Oxidative stress in women with perimenopausal symptoms

Menopause

Volumn 18, Issue 11, 2011, Pages 1249-1255

  Žitňanová, Ingrid ^a   Rakovan, Martin ^a   Paduchová, Zuzana ^a   Dvořáková, Monika ^a   Andrezálová, Lucia ^a   Muchová, Jana ^a   Šimko, Martin ^a   Waczulíková, Iveta ^b   Ďuračková, Zdeňka ^a  

^a Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^b Physics and Informatics   (Slovakia)

Author keywords

8 Oxoguanine; Climacteric symptoms; DNA repair ability; Homocysteine; Lipoperoxides; Paraoxonase

Indexed keywords

8 HYDROXYGUANINE; ARYLDIALKYLPHOSPHATASE 1; BIOCHEMICAL MARKER; CHOLESTEROL; GULONOLACTONE OXIDASE; HIGH DENSITY LIPOPROTEIN; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA REPAIR; ENZYME ACTIVITY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; OXIDATIVE STRESS;

ADULT; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DNA DAMAGE; DNA REPAIR; FEMALE; GUANINE; HUMANS; LIPID PEROXIDES; MIDDLE AGED; OXIDATIVE STRESS; PERIMENOPAUSE; PREMENOPAUSE; QUESTIONNAIRES;

EID: 80255123864     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e318224fa3d     Document Type: Article

References (43)

1. Salhotra S, Arora S, Anubhuti, Trivedi SS, Bhattacharjee J. Influence of menopause on biochemical markers of endothelial dysfunctionVa casecontrol pilot study in North Indian population. Maturitas 2009;62:166-170.
2. Mesali L, Tupkovi E, Kendi S, Bali D. Correlation between hormonal and lipid status in women in menopause. Bosn J Basic Med Sci 2008;8:188-192.
3. Thorin-Trescases N, Voghel G, Farhat N, Drouin A, Gendron MÈ , Thorin E. Age-dependent oxidative stress: toward an irreversible failure in endothelial maintenance. Med Sci (Paris) 2010;26:875-880.
4. Lakshmi SV, Padmaja G, Kuppusamy P, Kutala VK. Oxidative stress in cardiovascular disease. Indian J Biochem Biophys 2009;46:421-440.
5. Soran H, Younis NN, Charlton-Menys V, Durrington P. Variation in paraoxonase-1 activity and atherosclerosis. Curr Opin Lipidol 2009; 20:265-274.
6. Aviram M, Rosenblat M. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med 2004;37:1304-1316. (Pubitemid 39349234)
7. Shen L, Pisha E, Huang Z, et al. Bioreductive activation of catechol estrogen-ortho-quinones: aromatization of the B ring in 4-hydroxyequilenin markedly alters quinoid formation and reactivity. Carcinogenesis 1997;18:1093-1101. (Pubitemid 28132360)
8. Fraga CG, Shigenaga MK, Park J, Degan P, Ames BN. Oxidative damage to DNA during aging: 8-hydroxy-2¶-deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci USA 1990;87:4533-4537.
9. Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D. Estrogens as endogenous genotoxic agentsVDNA adducts and mutations. J Natl Cancer Inst Monogr 2000;27:75-93.
10. Potthoff P, Heinemann LAJ, Schneider HPG, Rosemeier HP, Hauser GA. Menopause-Rating Skala (MRS): Methodische Standardisierung in der deutschen Bevölkerung. Zentralbl Gynaekol 2000;122:280-286. (Pubitemid 30331860)
11. Dinger J, Zimmermann T, Heinemann LAJ, Stoehr D. Quality of life and hormone use? New validation results of MRS scale. Health Qual Life Outcomes 2006;4:32.
12. El-Saadani M, Esterbauer H, el-Sayed M, Goher M, Nassar AY, Jurgens G. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 1989;30:627-630. (Pubitemid 19107750)
13. Collins AR, Dobson VL, Duxinská M, Kennedy G, wtetina R. Comet assay: what can it really tell us? Mutat Res 1997;375:183-193. (Pubitemid 27226696)
14. ESCODD. Establishing the background level of base oxidation in human lymphocyte DNA: results of an interlaboratory validation study. FASEB J 2004;18:1-23.
15. Collins AR, Duxinská M, Horváthová E, Munro E, Savio M, Wttina R. Inter-individual differences in repair of DNA base oxidation, measured in vitro with the comet assay. Mutagenesis 2001;16:297-301. (Pubitemid 32684778)
16. Gan KN, Smolen A, Eckerson HW, La Du BN. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos 1991;19:100-106.
17. Aviram M, Rosenblat M. Paraoxonases (PON1, PON2, PON3) analyses in vitro and in vivo in relation to cardiovascular diseases. Methods Mol Biol 2008;477:259-276.
18. Heinemann K, Ruebig A, Potthoff P, et al. The Menopause Rating Scale (MRS) scale: a methodological review. Health Qual Life Outcomes 2004;2:45.
19. Avis N, Stellato R, Crawford S, et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic group. Soc Sci Med 2001;52:345-356.
20. Kravitz HM, Ganz PA, Bromberger J, Powell LH, Sutton-Tyrrell K, Meyer PM. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause 2003;10:19-28. (Pubitemid 36706318)
21. Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004;61:62-70. (Pubitemid 38044642)
22. Maoz B, Dowty N, Antonovsky A, Wisjenbeck H. Female attitudes to menopause. Soc Psychiatry 1970;5:35-40.
23. Chiechi LM, Putignano G, Guerra V, Schiavelli MP, Cisternino AM, Carriero C. The effect of a soy rich diet on the vaginal epithelium in postmenopause: a randomized double blind trial. Maturitas 2003;45: 241-246. (Pubitemid 36966736)
24. Cheng G, Wilczek B, Warner M, Gustafsson JA, Landgren BM. Isoflavone treatment for acute menopausal symptoms. Menopause 2007; 14:468-473.
25. Uesuqi T, Fukui Y, Yamori Y. Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal Japanese women: a four-week study. J Am Coll Nutr 2002;21:97-102. (Pubitemid 38639154)
26. Leal M, Díaz J, Serrano E, Abellán J, Carbonell LF. Hormone replacement therapy for oxidative stress in postmenopausal women with hot flushes. Obstet Gynecol 2000;95:804-809.
27. Bureau I, Laporte F, Favier M, et al. No antioxidant effect of combined HRT on LDL oxidizability and oxidative stress biomarkers in treated post-menopausal women. J Am Coll Nutr 2002;21:333-338. (Pubitemid 34832553)
28. Top0uoglu A, Uzun H, Aydin S, et al. The effect of hormone replacement therapy on oxidized low density lipoprotein levels and paraoxonase activity in postmenopausal women. Tohoku J Exp Med 2005;205:79-86. (Pubitemid 40260057)
29. Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation 1997; 95:252-264. (Pubitemid 27029969)
30. Baal WM, Kooistra T, Stehouwer CD. Cardiovascular disease risk and hormone replacement therapy (HRT): a review based on randomized, controlled studies in postmenopausal women. Curr Med Chem 2000; 7:499-517. (Pubitemid 30396425)
31. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med 1986;314:488-500.
32. Stenberg D, Parthasarathy S, Carew TE, Khoo JC, Witzum JL. Beyond cholesterol. N Engl J Med 1989;320:915-924.
33. Jayakumari N, Thejaseebai G. High prevalence of low serum paraoxonase-1 in subjects with coronary artery disease. J Clin Biochem Nutr 2009;45:278-284.
34. Ferretti G, Bacchetti T, Moroni C, et al. Paraoxonase activity in highdensity lipoproteins: a comparison between healthy and obese females. J Clin Endocrinol Metab 2005;90:1728-1733. (Pubitemid 40464045)
35. Watson AD, Berliner JA, Hama SY, et al. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 1995;96:2882-2891.
36. Ferretti G, Bacchetti T, Marotti E, Curatola G. Effect of homocysteinylation on human high-density lipoproteins: a correlation with paraoxonase activity. Metabolism 2003;52:146-151. (Pubitemid 36388834)
37. Bhat HK, Calaf G, Hei TK, Loya T, Vadgama JV. Critical role of oxidative stress in estrogen-induced carcinogenesis. Proc Natl Acad Sci USA 2003;100:3913-3918. (Pubitemid 36418131)
38. Wang Y-J, Ho Y-S, Lo M-J, Lin J. Oxidative modification of DNA bases in rat liver and lung during chemical carcinogenesis and aging. Chem Biol Interact 1995;94:135-145.
39. Kaneko T, Tahara SM, Matsuo M. Non-linear accumulation of 8〈hydroxy-2¶-deoxyguanosine, a marker of oxidized DNA damage, during aging. Mutat Res 1996;316:277-285. (Pubitemid 26179270)
40. Sai K, Takagi A, Umemura T, Hasegawa R, Kurokawa Y. Changes of 8-hydroxydeoxyguanosine levels in rat organ DNA during the aging process. J Environ Pathol Toxicol Oncol 1992;11:139-143.
41. Anson RM, Senturker S, Dizdaroglu M, Bohr VA. Measurement of oxidatively induced base lesions in liver from Wistar rats of different ages. Free Radic Biol Med 1999;27:456-462. (Pubitemid 29395441)
42. Fraga CG, Shigenaga MK, Park J, Degan P, Ames BN. Oxidative damage to DNA during aging: 8-hydroxy-2¶-deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci USA 1990;87:4533-4537.
43. Wang Y-J, Ho Y-S, Lo M-J, Lin J. Oxidative modification of DNA bases in rat liver and lung during chemical carcinogenesis and aging. Chem Biol Interact 1995;94:135-145.